Peripheral Artery Disease Market
Report ID: SQMIG35A2750
Report ID: SQMIG35A2750
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A2750 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
90
|Figures:
68
Peripheral Artery Disease Market size was valued at USD 5.85 Billion in 2024 and is poised to grow from USD 6.46 Billion in 2025 to USD 14.25 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026–2033).
Surveys indicate that approximately 6.5 million individuals aged 40 and older in the United States are affected by Peripheral Artery Disease (PAD). Both men and women are susceptible to PAD, but statistics reveal that African Americans face an elevated risk of developing this condition. The aging demographic contributes significantly to the rise in PAD prevalence, as the likelihood of developing vascular diseases increases with age. Additionally, the continuous aging of the population is accompanied by an uptick in product approvals related to the diagnosis, management, and treatment of PAD. These factors collectively amplify the overall risk of developing peripheral arterial disease. The intersection of demographic shifts, increased disease prevalence, and advancements in medical technology underscores the multifaceted nature of the risk factors associated with PAD in the United States.
Market snapshot - 2026-2033
Global Market Size
USD 5.3 billion
Largest Segment
Peripheral Stents
Fastest Growth
Peripheral Angioplasty Balloons
Growth Rate
10.4% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In 2023, the peripheral stents segment emerged as the predominant contributor to the overall market, exhibiting substantial growth with a projected CAGR of 7.5% during the forecast period. Peripheral stents play a pivotal role in addressing vascular complications, as they are designed to treat narrowing or blockages within arteries or veins. These small tubular metal scaffolds are strategically inserted into peripheral vessels, facilitating the restoration and enhancement of blood flow.
In 2023, the peripheral angioplasty balloons segment is anticipated to experience a robust CAGR of 8.9%, marking it as a high-growth component within the peripheral arterial disease market. Peripheral angioplasty balloons play a crucial role in widening narrowed arteries during angioplasty procedures. This intervention involves the use of a wire to guide an empty balloon catheter into constricted arteries, positioning it precisely for the desired outcome. Upon reaching the target location, the balloon is inflated, displacing stenosis or narrowing on the vessel wall.
The ambulatory surgical clinics segment plays a crucial role in the peripheral artery disease (PAD) market, contributing significantly to the overall landscape of vascular interventions. Ambulatory surgical clinics are pivotal healthcare facilities that specialize in providing outpatient surgical procedures, including those related to peripheral artery disease. These clinics offer a convenient and efficient alternative to traditional hospital settings, allowing for streamlined patient care, reduced waiting times, and cost-effective treatments.
The hospitals & clinics category has emerged as the leading revenue generator within the peripheral arterial disease market. The robust financial performance of this segment is expected to experience further augmentation driven by several factors. The anticipated growth in healthcare capital equipment expenditures is poised to play a pivotal role, reflecting the increasing investment in advanced medical technologies and equipment within hospital and clinic settings. Additionally, the favorable impact of technology, specifically the utilization of lifeline curves, is anticipated to contribute to segmental growth.
To get detailed segments analysis, Request a Free Sample Report
North America currently holds a dominant position in the peripheral artery disease (PAD) market, driven by continuous advancements in the latest technologies. The region's commitment to technological innovation contributes significantly to the growth of the PAD market, as it fosters the development of cutting-edge diagnostic and therapeutic solutions. Additionally, the introduction of innovative drug molecules aimed at enhancing treatment procedures further augments the market's expansion in North America throughout the forecast period.
Asia-Pacific is poised to witness substantial growth in the PAD market, primarily attributed to the increasing patient pool in the region. The rising prevalence of peripheral arterial disease underscores the demand for advanced healthcare solutions. Furthermore, significant investments in the healthcare sector within Asia-Pacific are expected to act as a catalyst, propelling the growth of the PAD market in the region in the forthcoming years. This combination of a burgeoning patient population and strategic investments positions Asia-Pacific as a key growth hub in the global PAD market landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rise in the Elderly Population
Concerns Regarding Product Recalls
Request Free Customization of this report to help us to meet your business objectives.
The competitive environment of the global Peripheral Artery Disease market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global Peripheral Artery Disease marketplace analysis exhibits a dynamic marketplace with some of standout developments and problems. The CAGR of the peripheral artery disease market is being notably influenced by the rising demand for minimally invasive procedures. The heightened preference for less invasive interventions is a key driver shaping the market dynamics. However, the parallel surge in peripheral arterial disease (PAD) cases is exerting a counteracting effect, negatively impacting the market's overall expansion. The prevalence of PAD, affecting over 200 million individuals globally and linked to elevated mortality and morbidity rates, is underscored in the American Heart Association's 2021 report.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 5.85 Billion |
| Market size value in 2033 | USD 14.25 Billion |
| Growth Rate | 10.4% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Peripheral Artery Disease Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peripheral Artery Disease Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peripheral Artery Disease Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peripheral Artery Disease Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
